Association of CYP1A1 gene polymorphism with chronic kidney disease: A case control study

Environmental Toxicology and Pharmacology

Volumn 36, Issue 1, 2013, Pages 164-170

  Siddarth, Manushi ^a   Datta, Sudip K ^a   Ahmed, Rafat S ^a   Banerjee, Basu D ^a   Kalra, Om P ^a   Tripathi, Ashok K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Chronic kidney disease; CYP1A1; Gene polymorphism

Indexed keywords

CYTOCHROME P450 1A1;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYP1A1 GENE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENAL INSUFFICIENCY, CHRONIC;

EID: 84876707049     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.03.008     Document Type: Article

References (33)

1. Achour A., Zaag I., Gueddah L., Trimeche B., Slama F.B.H., Zemni R. Role of CYP1A1 (T6235C) polymorphism and cigarette smoking in the development of coronary heart disease in Tunisian population. J. Genet. 2011, 90:203-208.
2. Ahmad S.T., Arjumand W., Seth A., Nafees S., rashid S., Ali N., Hamiza O.O., Sultana S. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes. Urol. Oncol. 2012.
3. Anantharaman D., Chaubal P.M., Kannan S., Bhisey R.A., Mahimkar M.B. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure a risk modulator. Cacinogenesis 2007, 28:1455-1462.
4. Bailey L.R., Roodi N., Verrier C.S., Yee C.J., Dupont W.D., Parl F.F. Breast cancer and CYP1A1, GSTM1 and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and Africans Americans. Cancer Res. 1998, 58:65-70.
5. Ball S., Lloyd J., Cairns T., Cook T., Palmer A., Cattell V., Taube D. Why is there so much end-stage renal failure of undetermined cause in UK Indo-Asians?. QJM 2001, 94:187-193.
6. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomar. Prev. 2000, 9:3-28.
7. Chen J., Cheng M., Li Y., Jiang C. Relationship between CYP1A1 genetic polymorphism and renal cancer in China. Asia. Pac. J. Cancer Prev. 2011, 12:2163-2166.
8. Hu W., Sorrentino C., Denison M.S., Kolaja K., Fielden M.R. Induction of Cyp1A1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol. Pharmacol. 2007, 71:1475-1486.
9. Kiyohara C., Hirohata T., Inutsuka S. The relationship between aryl hydrocarbons hydroxylase and polymorphisms of the CYP1A1 gene. Jpn. J. Cancer Res. 1996, 87:18-24.
10. Kopf P.G., Walker M.K. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1. Toxicol. Appl. Pharmacol. 2010, 245:91-99.
11. Kumar V., Singh S., Yadav C.S., Ahmed R.S., Gupta S., Pasha S.T., Tripathi A.K., Banerjee B.D. CYP1A1 and CYP3A4 polymorphic variations in Delhi population of Northern India. Environ. Toxicol. Pharmacol. 2010, 29:126-130.
12. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y., Castro A.F., Feldman H.I., Zhang Y., John W., Kusek J.W., Eggers P., Lente F.V., Greene T., Coresh J. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 9:604-612.
13. Li Y., Milikan R., Bell D., Cui L., Tse C.K., Newman B., Conway K. Cigarette smoking cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res. 2004, 6:R460-R473.
14. Longuemaux S., Delomenie C., Gallou C., Mejean A., Vincent-Viry M., Bouvier R., Droz D., Krishnamoorthy R., Galteau M.M., Junien C., Beroud C., Dupret J.M. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res. 1999, 59:2903-2908.
15. Lu C.F., Wang Y.M., Peng S.Q., Zou L.B., Tan D.H., Liu G., Fu Z., Wang Q.X., Zhao J. Combined effects of repeated administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin and polychlorinated biphenyls on kidneys of male rats. Arch. Environ. Contam. Toxicol. 2009, 57:767-776.
16. Majumdar P.P., Mukherjee B.N. Genetic diversity and affinities among Indian populations: an overview. Human Population Genetics 1993, 255-275. Plenum Press, New York. P.P. Majumdar (Ed.).
17. Masson L.F., Sharp L., Cotton S.C., Little J. Cytochrome P-450 1A1 gene polymorphism and risk of breast cancer: a huge review. Am. J. Epidemiol. 2005, 161:901-915.
18. Mittal R.D., Srivastava D.L. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA Cell Biol. 2007, 26:791-798.
19. Rajapurkar M.M., John G.T., Kirpalani A.L., Abraham G., Agarwal S.K., Almeida A.F., Gang S., Gupta A., Modi G., Pahari D., Pisharody R., Prakash J., Raman A., Rana D.S., Sharma R.K., Sahoo R.N., Sakhuja V., Tatapudi R.R., Jha V. What we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012, 13:1-8.
20. Rodriguez S., Gaunt R.T., Day I.N.M. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am. J. Epidemiol. Adv. Access 2009, 169:505-514.
21. Sergentanis T.N., Economopoulos K.P. Four polymorphism in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta analysis. Breast Cancer Res. Treat. 2010, 122:459-469.
22. Siddharth M., Datta S.K., Bansal S., Mustafa M., Banerjee B.D., Kalra O.P., Tripathi A.K. Study on organochlorine pesticide levels in chronic kidney disease patients: association with estimated glomerular filtration rate and oxidative stress. J. Biochem. Mol. Toxicol. 2012, 26:241-247.
23. Smits K.M., Schouten L.J., Van Dijk B.A. Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from the Netherlands Cohort Study on diet and cancer. World J. Urol. 2008, 26:103-110.
24. Sobti R.C., Sharma S., Joshi A., Jindal S.K., Janmeja A. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a North Indian population. Mol. Cell. Biochem. 2004, 266:1-9.
25. Soderland P., Lovekar S., Weiner D.E., Brooks D.R., Kaufman J.S. Chronic kidney disease associated with environmental toxins and exposures. Adv. Chronic Kidney Dis. 2010, 17:254-264.
26. Sreeja L., Syamala V., Hariharan S., Madhavan J., Devan S.C., Ankathil R. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphism in lung cancer susceptibility in a south Indian population. J. Hum. Genet. 2005, 50:618-627.
27. Srivastava D.S., Madhani A., Mittal R.D. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch. Toxicol. 2008, 82:633-639.
28. Suryanarayana V., Deendayal M., Singh L. Association of CYP1A1 gene polymorphism with recurrent pregnancy loss in south Indian population. Hum. Reprod. 2004, 19:2648-2652.
29. Taioli E., Ford J., Trachman J., Li Y., Demopoulos R., Garte S. Lung cancer risk and CYP1A1 genotype in Africans Americans. Carcinogenesis 1998, 19:813-817.
30. Wang G.P., Zhang P., Xu M. Association of genetic polymorphisms in CYP1A1 and NAT2 with susceptibility to renal cancer: a case control study. Acad. J. Sec. Military Med. Univ. 2008, 29:1147-1152.
31. Wang X.L., Greco M., Sim A.S., Duarte N., Wang J., Wilcken D.E.L. Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis 2002, 162:391-397.
32. Wright C.M., Larsen J.E., Colosimo M.L., Barr J.J., Chen L., McLachlan R.E., Yang I.A., Bowman R.V., Fong K.M. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur. Respir. J. 2010, 35:152-159.
33. Garte S.J., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L. Metabolic gene polymorphism frequencies in control population. Cancer Epidemiol. Biomar. Prev. 2001, 10:1239-1248.